Exposure to formaldehyde and asthma outcomes: A systematic review, meta-analysis, and economic assessment
PloS One
Juleen Lam, Erica Koustas,
Patrice Sutton, Amy M. Padula,
Michael D. Cabana, Tracey J. Woodruff, et al.
Every major federal regulation in the United States requires an economic analysis estimating its benefits and costs. Benefit-cost analyses related to regulations on formaldehyde exposure have not included asthma in part due to lack of clarity in the strength of the evidence.
Read more
The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill
Medical Care Research and Review
Thuy Nguyen, Ulrike Muench,
Barbara Andraka-Christou, Joanne Spetz, et al.
This article examines the relationship between federal regulations, state scope-of-practice regulations on nurse practitioners (NPs), and buprenorphine prescribing patterns using pharmacy claims data from Optum’s deidentified Clinformatics Data Mart between January 2015 and September 2018.
Read more
COVID-19 reveals need to increase diversity among California physicians
CalMatters
Janet Coffman and Alicia Fernández
COVID-19 has revealed serious flaws in our health system, but none is more distressing than the deep racial and ethnic inequality exposed by the pandemic. With Latinx and Black people dying at higher rates than the rest of the population, communities of color are much more likely than other groups to say they’re having trouble accessing telehealth services and paying medical bills.
Read more
